Tanzania
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
3.54 (3.43 - 3.66) | 2019 | Modelled | IHME |
3.63 (3.53 - 3.74) | 2018 | Modelled | IHME |
3.77 (3.66 - 3.89) | 2017 | Modelled | IHME |
3.99 (3.87 - 4.11) | 2016 | Modelled | IHME |
4.22 (4.10 - 4.37) | 2015 | Modelled | IHME |
4.39 (4.26 - 4.54) | 2014 | Modelled | IHME |
4.52 (4.40 - 4.68) | 2013 | Modelled | IHME |
4.65 (4.52 - 4.81) | 2012 | Modelled | IHME |
4.78 (4.64 - 4.95) | 2011 | Modelled | IHME |
4.92 (4.77 - 5.11) | 2010 | Modelled | IHME |
5.09 (4.93 - 5.27) | 2009 | Modelled | IHME |
5.27 (5.11 - 5.45) | 2008 | Modelled | IHME |
5.45 (5.28 - 5.65) | 2007 | Modelled | IHME |
5.63 (5.45 - 5.86) | 2006 | Modelled | IHME |
5.8 (5.60 - 6.05) | 2005 | Modelled | IHME |
5.97 (5.76 - 6.23) | 2004 | Modelled | IHME |
6.15 (5.92 - 6.42) | 2003 | Modelled | IHME |
6.32 (6.08 - 6.60) | 2002 | Modelled | IHME |
6.47 (6.22 - 6.77) | 2001 | Modelled | IHME |
6.57 (6.30 - 6.91) | 2000 | Modelled | IHME |
6.64 (6.37 - 6.98) | 1999 | Modelled | IHME |
6.69 (6.43 - 7.04) | 1998 | Modelled | IHME |
6.74 (6.47 - 7.09) | 1997 | Modelled | IHME |
6.78 (6.50 - 7.15) | 1996 | Modelled | IHME |
6.83 (6.53 - 7.22) | 1995 | Modelled | IHME |
6.88 (6.59 - 7.25) | 1994 | Modelled | IHME |
6.93 (6.66 - 7.31) | 1993 | Modelled | IHME |
6.98 (6.71 - 7.36) | 1992 | Modelled | IHME |
7.03 (6.74 - 7.42) | 1991 | Modelled | IHME |
7.08 (6.78 - 7.47) | 1990 | Modelled | IHME |
3.5 (2.10 - 5) | 2017 | Survey/reported | Tanzania HIV Impact Survey (THIS) 2016-2017, 2018 |
4.03 (3.06 - 5.16) | 2015 | Modelled | WHO |
4.1 (3.20 - 5.40) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
7.17 (6.59 - 7.79) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.38 (0.31 - 0.45) | 2019 | Modelled | IHME |
0.41 (0.34 - 0.50) | 2018 | Modelled | IHME |
0.44 (0.36 - 0.55) | 2017 | Modelled | IHME |
0.47 (0.39 - 0.56) | 2016 | Modelled | IHME |
0.49 (0.40 - 0.59) | 2015 | Modelled | IHME |
0.5 (0.42 - 0.60) | 2014 | Modelled | IHME |
0.51 (0.43 - 0.60) | 2013 | Modelled | IHME |
0.52 (0.43 - 0.62) | 2012 | Modelled | IHME |
0.53 (0.44 - 0.64) | 2011 | Modelled | IHME |
0.55 (0.45 - 0.66) | 2010 | Modelled | IHME |
0.59 (0.49 - 0.71) | 2009 | Modelled | IHME |
0.67 (0.55 - 0.80) | 2008 | Modelled | IHME |
0.77 (0.64 - 0.92) | 2007 | Modelled | IHME |
0.9 (0.76 - 1.07) | 2006 | Modelled | IHME |
1.06 (0.88 - 1.27) | 2005 | Modelled | IHME |
1.43 (1.20 - 1.71) | 2004 | Modelled | IHME |
2.06 (1.73 - 2.47) | 2003 | Modelled | IHME |
2.77 (2.33 - 3.33) | 2002 | Modelled | IHME |
3.36 (2.81 - 4.09) | 2001 | Modelled | IHME |
3.66 (3.02 - 4.50) | 2000 | Modelled | IHME |
3.73 (3.08 - 4.62) | 1999 | Modelled | IHME |
3.78 (3.11 - 4.75) | 1998 | Modelled | IHME |
3.82 (3.11 - 4.80) | 1997 | Modelled | IHME |
3.85 (3.11 - 4.85) | 1996 | Modelled | IHME |
3.88 (3.10 - 4.92) | 1995 | Modelled | IHME |
3.91 (3.15 - 4.91) | 1994 | Modelled | IHME |
3.95 (3.20 - 4.92) | 1993 | Modelled | IHME |
3.98 (3.24 - 4.92) | 1992 | Modelled | IHME |
4.01 (3.29 - 4.92) | 1991 | Modelled | IHME |
4.03 (3.31 - 4.99) | 1990 | Modelled | IHME |
1.69 (1.08 - 2.54) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
1,834,400 (1,755,700 - 1,934,320) | 1990 | Modelled | IHME |
1,875,780 (1,797,450 - 1,977,830) | 1991 | Modelled | IHME |
1,917,540 (1,841,610 - 2,020,150) | 1992 | Modelled | IHME |
1,959,580 (1,881,450 - 2,066,330) | 1993 | Modelled | IHME |
2,001,810 (1,917,750 - 2,109,480) | 1994 | Modelled | IHME |
2,044,120 (1,954,770 - 2,159,320) | 1995 | Modelled | IHME |
2,087,730 (2,002,010 - 2,201,390) | 1996 | Modelled | IHME |
2,132,660 (2,047,050 - 2,242,850) | 1997 | Modelled | IHME |
2,177,070 (2,089,900 - 2,290,240) | 1998 | Modelled | IHME |
2,219,050 (2,128,590 - 2,332,510) | 1999 | Modelled | IHME |
2,256,440 (2,165,380 - 2,372,240) | 2000 | Modelled | IHME |
2,281,540 (2,193,250 - 2,389,070) | 2001 | Modelled | IHME |
2,291,050 (2,201,480 - 2,391,930) | 2002 | Modelled | IHME |
2,289,450 (2,203,920 - 2,388,030) | 2003 | Modelled | IHME |
2,282,060 (2,200,920 - 2,379,680) | 2004 | Modelled | IHME |
2,274,770 (2,195,620 - 2,373,230) | 2005 | Modelled | IHME |
2,265,750 (2,192,790 - 2,357,150) | 2006 | Modelled | IHME |
2,250,820 (2,180,520 - 2,333,500) | 2007 | Modelled | IHME |
2,232,990 (2,165,520 - 2,310,660) | 2008 | Modelled | IHME |
2,215,220 (2,148,340 - 2,294,760) | 2009 | Modelled | IHME |
2,200,860 (2,133,520 - 2,283,590) | 2010 | Modelled | IHME |
2,193,940 (2,130,040 - 2,271,640) | 2011 | Modelled | IHME |
2,192,440 (2,130,440 - 2,267,600) | 2012 | Modelled | IHME |
2,190,500 (2,129,730 - 2,265,480) | 2013 | Modelled | IHME |
2,181,280 (2,116,920 - 2,256,710) | 2014 | Modelled | IHME |
2,157,060 (2,092,360 - 2,233,880) | 2015 | Modelled | IHME |
2,091,360 (2,031,910 - 2,158,540) | 2016 | Modelled | IHME |
2,027,820 (1,969,110 - 2,095,990) | 2017 | Modelled | IHME |
2,005,750 (1,951,100 - 2,066,390) | 2018 | Modelled | IHME |
2,008,560 (1,948,220 - 2,074,120) | 2019 | Modelled | IHME |
2,261,000 (1,755,000 - 3,022,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
2.82 (1.81 - 4.06) | 2019 | Modelled | IHME |
3.02 (1.94 - 4.31) | 2018 | Modelled | IHME |
3.1 (2.02 - 4.42) | 2017 | Modelled | IHME |
3.01 (1.96 - 4.29) | 2016 | Modelled | IHME |
2.97 (1.94 - 4.21) | 2015 | Modelled | IHME |
3.15 (2.08 - 4.41) | 2014 | Modelled | IHME |
3.51 (2.35 - 4.81) | 2013 | Modelled | IHME |
3.92 (2.70 - 5.33) | 2012 | Modelled | IHME |
4.3 (3.02 - 5.86) | 2011 | Modelled | IHME |
4.59 (3.27 - 6.11) | 2010 | Modelled | IHME |
4.73 (3.41 - 6.24) | 2009 | Modelled | IHME |
4.84 (3.54 - 6.37) | 2008 | Modelled | IHME |
4.92 (3.56 - 6.53) | 2007 | Modelled | IHME |
4.97 (3.65 - 6.53) | 2006 | Modelled | IHME |
5.04 (3.69 - 6.64) | 2005 | Modelled | IHME |
5.07 (3.71 - 6.59) | 2004 | Modelled | IHME |
5.09 (3.75 - 6.74) | 2003 | Modelled | IHME |
5.11 (3.75 - 6.76) | 2002 | Modelled | IHME |
5.22 (3.84 - 6.93) | 2001 | Modelled | IHME |
5.17 (3.73 - 6.87) | 2000 | Modelled | IHME |
5.06 (3.63 - 6.69) | 1999 | Modelled | IHME |
4.86 (3.52 - 6.49) | 1998 | Modelled | IHME |
4.9 (3.55 - 6.62) | 1997 | Modelled | IHME |
4.93 (3.57 - 6.70) | 1996 | Modelled | IHME |
4.99 (3.59 - 6.79) | 1995 | Modelled | IHME |
5.06 (3.65 - 6.90) | 1994 | Modelled | IHME |
5.12 (3.68 - 7.01) | 1993 | Modelled | IHME |
5.15 (3.67 - 7.01) | 1992 | Modelled | IHME |
5.21 (3.71 - 7.01) | 1991 | Modelled | IHME |
5.27 (3.75 - 7.15) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
1,602 (1,027 - 2,303) | 2019 | Modelled | IHME |
1,668 (1,072 - 2,384) | 2018 | Modelled | IHME |
1,671 (1,088 - 2,383) | 2017 | Modelled | IHME |
1,580 (1,028 - 2,249) | 2016 | Modelled | IHME |
1,520 (990 - 2,152) | 2015 | Modelled | IHME |
1,568 (1,034 - 2,196) | 2014 | Modelled | IHME |
1,702 (1,140 - 2,331) | 2013 | Modelled | IHME |
1,848 (1,272 - 2,511) | 2012 | Modelled | IHME |
1,973 (1,388 - 2,691) | 2011 | Modelled | IHME |
2,050 (1,462 - 2,729) | 2010 | Modelled | IHME |
2,058 (1,485 - 2,715) | 2009 | Modelled | IHME |
2,051 (1,503 - 2,700) | 2008 | Modelled | IHME |
2,031 (1,472 - 2,696) | 2007 | Modelled | IHME |
2,001 (1,470 - 2,628) | 2006 | Modelled | IHME |
1,977 (1,448 - 2,604) | 2005 | Modelled | IHME |
1,935 (1,416 - 2,517) | 2004 | Modelled | IHME |
1,896 (1,395 - 2,510) | 2003 | Modelled | IHME |
1,852 (1,359 - 2,450) | 2002 | Modelled | IHME |
1,840 (1,353 - 2,445) | 2001 | Modelled | IHME |
1,775 (1,281 - 2,360) | 2000 | Modelled | IHME |
1,693 (1,214 - 2,236) | 1999 | Modelled | IHME |
1,582 (1,144 - 2,110) | 1998 | Modelled | IHME |
1,552 (1,123 - 2,096) | 1997 | Modelled | IHME |
1,518 (1,099 - 2,062) | 1996 | Modelled | IHME |
1,493 (1,074 - 2,032) | 1995 | Modelled | IHME |
1,472 (1,062 - 2,008) | 1994 | Modelled | IHME |
1,446 (1,041 - 1,981) | 1993 | Modelled | IHME |
1,415 (1,007 - 1,924) | 1992 | Modelled | IHME |
1,390 (991 - 1,869) | 1991 | Modelled | IHME |
1,365 (972 - 1,852) | 1990 | Modelled | IHME |
2,750 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
25 (19 - 33) | 2019 | Modelled | IHME |
25 (19 - 33) | 2018 | Modelled | IHME |
25 (19 - 33) | 2017 | Modelled | IHME |
25 (19 - 33) | 2016 | Modelled | IHME |
25 (19 - 32) | 2015 | Modelled | IHME |
25 (19 - 33) | 2014 | Modelled | IHME |
25 (19 - 32) | 2013 | Modelled | IHME |
25 (19 - 33) | 2012 | Modelled | IHME |
26 (20 - 33) | 2011 | Modelled | IHME |
26 (20 - 34) | 2010 | Modelled | IHME |
26 (20 - 34) | 2009 | Modelled | IHME |
26 (20 - 34) | 2008 | Modelled | IHME |
26 (19 - 33) | 2007 | Modelled | IHME |
26 (19 - 33) | 2006 | Modelled | IHME |
26 (19 - 34) | 2005 | Modelled | IHME |
26 (20 - 34) | 2004 | Modelled | IHME |
26 (20 - 34) | 2003 | Modelled | IHME |
26 (20 - 34) | 2002 | Modelled | IHME |
26 (20 - 34) | 2001 | Modelled | IHME |
26 (20 - 34) | 2000 | Modelled | IHME |
27 (20 - 34) | 1999 | Modelled | IHME |
27 (21 - 35) | 1998 | Modelled | IHME |
27 (21 - 35) | 1997 | Modelled | IHME |
27 (21 - 35) | 1996 | Modelled | IHME |
27 (21 - 35) | 1995 | Modelled | IHME |
27 (20 - 35) | 1994 | Modelled | IHME |
27 (20 - 35) | 1993 | Modelled | IHME |
26 (20 - 35) | 1992 | Modelled | IHME |
26 (20 - 34) | 1991 | Modelled | IHME |
26 (20 - 34) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
98 | 2018 | Survey/reported | WHO/UNICEF |
97 | 2017 | Survey/reported | WHO/UNICEF |
97 | 2016 | Survey/reported | WHO/UNICEF |
98 | 2015 | Survey/reported | WHO/UNICEF |
97 | 2014 | Survey/reported | WHO/UNICEF |
91 | 2013 | Survey/reported | WHO/UNICEF |
92 | 2012 | Survey/reported | WHO/UNICEF |
90 | 2011 | Survey/reported | WHO/UNICEF |
91 | 2010 | Survey/reported | WHO/UNICEF |
85 | 2009 | Survey/reported | WHO/UNICEF |
86 | 2008 | Survey/reported | WHO/UNICEF |
83 | 2007 | Survey/reported | WHO/UNICEF |
90 | 2006 | Survey/reported | WHO/UNICEF |
90 | 2005 | Survey/reported | WHO/UNICEF |
95 | 2004 | Survey/reported | WHO/UNICEF |
95 | 2003 | Survey/reported | WHO/UNICEF |
89 | 2002 | Survey/reported | WHO/UNICEF |
89 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
2 (1 - 3) | 2016 | Survey/reported | Larney S et al, 2017 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.48 (1.17 - 1.85) | 2019 | Modelled | IHME |
1.47 (1.17 - 1.84) | 2018 | Modelled | IHME |
1.47 (1.17 - 1.83) | 2017 | Modelled | IHME |
1.46 (1.18 - 1.82) | 2016 | Modelled | IHME |
1.45 (1.17 - 1.81) | 2015 | Modelled | IHME |
1.45 (1.18 - 1.81) | 2014 | Modelled | IHME |
1.45 (1.17 - 1.81) | 2013 | Modelled | IHME |
1.45 (1.17 - 1.82) | 2012 | Modelled | IHME |
1.45 (1.16 - 1.82) | 2011 | Modelled | IHME |
1.45 (1.16 - 1.82) | 2010 | Modelled | IHME |
1.45 (1.16 - 1.82) | 2009 | Modelled | IHME |
1.46 (1.17 - 1.82) | 2008 | Modelled | IHME |
1.47 (1.17 - 1.83) | 2007 | Modelled | IHME |
1.48 (1.18 - 1.84) | 2006 | Modelled | IHME |
1.48 (1.18 - 1.84) | 2005 | Modelled | IHME |
1.48 (1.19 - 1.84) | 2004 | Modelled | IHME |
1.48 (1.19 - 1.84) | 2003 | Modelled | IHME |
1.48 (1.20 - 1.83) | 2002 | Modelled | IHME |
1.48 (1.20 - 1.83) | 2001 | Modelled | IHME |
1.48 (1.20 - 1.84) | 2000 | Modelled | IHME |
1.48 (1.20 - 1.84) | 1999 | Modelled | IHME |
1.48 (1.19 - 1.84) | 1998 | Modelled | IHME |
1.47 (1.18 - 1.83) | 1997 | Modelled | IHME |
1.47 (1.18 - 1.84) | 1996 | Modelled | IHME |
1.47 (1.18 - 1.85) | 1995 | Modelled | IHME |
1.47 (1.18 - 1.84) | 1994 | Modelled | IHME |
1.47 (1.19 - 1.84) | 1993 | Modelled | IHME |
1.48 (1.19 - 1.84) | 1992 | Modelled | IHME |
1.48 (1.19 - 1.86) | 1991 | Modelled | IHME |
1.49 (1.20 - 1.87) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.27 (0.21 - 0.36) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1 | 2017 | Survey/reported | Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018 |
2.7 (0.20 - 7.80) | 2014 | Modelled | Riou et al, 2015 |
3.2 | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
Showing out of
Show more
Men who have sex with men (MSM)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
8.9 | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
People living with HIV (PLHIV)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.5 | 2017 | Survey/reported | Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), 2018 |
Men who have sex with men (MSM) Living with HIV
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
41.5 (29.40 - 54.40) | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
27.7 (22.40 - 33.50) | 2011 | Survey/reported | Bowring AL et al, 2013 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
385,057 (309,934 - 483,453) | 1990 | Modelled | IHME |
395,001 (318,523 - 495,295) | 1991 | Modelled | IHME |
405,420 (326,424 - 506,400) | 1992 | Modelled | IHME |
416,348 (335,141 - 521,337) | 1993 | Modelled | IHME |
427,829 (344,527 - 535,980) | 1994 | Modelled | IHME |
439,906 (353,698 - 552,663) | 1995 | Modelled | IHME |
452,818 (362,618 - 567,262) | 1996 | Modelled | IHME |
466,549 (374,390 - 580,402) | 1997 | Modelled | IHME |
480,775 (387,006 - 599,046) | 1998 | Modelled | IHME |
495,168 (400,113 - 614,793) | 1999 | Modelled | IHME |
509,346 (410,966 - 631,589) | 2000 | Modelled | IHME |
523,345 (422,833 - 646,460) | 2001 | Modelled | IHME |
537,464 (433,146 - 664,240) | 2002 | Modelled | IHME |
551,660 (443,784 - 683,286) | 2003 | Modelled | IHME |
565,941 (454,770 - 702,022) | 2004 | Modelled | IHME |
580,313 (463,739 - 719,933) | 2005 | Modelled | IHME |
593,831 (474,405 - 740,215) | 2006 | Modelled | IHME |
606,214 (485,227 - 754,887) | 2007 | Modelled | IHME |
618,524 (496,141 - 771,239) | 2008 | Modelled | IHME |
631,842 (504,710 - 792,765) | 2009 | Modelled | IHME |
647,379 (517,628 - 815,871) | 2010 | Modelled | IHME |
664,858 (533,640 - 835,359) | 2011 | Modelled | IHME |
683,128 (550,467 - 857,693) | 2012 | Modelled | IHME |
702,208 (566,858 - 876,204) | 2013 | Modelled | IHME |
722,006 (584,718 - 902,225) | 2014 | Modelled | IHME |
742,375 (598,368 - 925,660) | 2015 | Modelled | IHME |
765,422 (617,947 - 953,915) | 2016 | Modelled | IHME |
789,783 (630,695 - 983,297) | 2017 | Modelled | IHME |
813,215 (648,932 - 1,015,680) | 2018 | Modelled | IHME |
837,035 (662,412 - 1,049,910) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
37,100 (28,600 - 49,200) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
5.63 (3.78 - 7.84) | 2019 | Modelled | IHME |
5.6 (3.77 - 7.73) | 2018 | Modelled | IHME |
5.6 (3.82 - 7.61) | 2017 | Modelled | IHME |
5.57 (3.80 - 7.65) | 2016 | Modelled | IHME |
5.65 (3.85 - 7.70) | 2015 | Modelled | IHME |
5.74 (4 - 7.71) | 2014 | Modelled | IHME |
5.8 (4.15 - 7.78) | 2013 | Modelled | IHME |
5.81 (4.23 - 7.73) | 2012 | Modelled | IHME |
5.87 (4.34 - 7.65) | 2011 | Modelled | IHME |
6.07 (4.51 - 7.89) | 2010 | Modelled | IHME |
6.26 (4.70 - 8.11) | 2009 | Modelled | IHME |
6.44 (4.85 - 8.30) | 2008 | Modelled | IHME |
6.58 (4.93 - 8.45) | 2007 | Modelled | IHME |
6.68 (5.01 - 8.60) | 2006 | Modelled | IHME |
6.78 (5.04 - 8.73) | 2005 | Modelled | IHME |
6.8 (5.07 - 8.70) | 2004 | Modelled | IHME |
6.8 (5.08 - 8.78) | 2003 | Modelled | IHME |
6.78 (5.15 - 8.71) | 2002 | Modelled | IHME |
6.86 (5.25 - 8.77) | 2001 | Modelled | IHME |
6.75 (5.17 - 8.64) | 2000 | Modelled | IHME |
6.57 (5.05 - 8.47) | 1999 | Modelled | IHME |
6.26 (4.80 - 8.05) | 1998 | Modelled | IHME |
6.34 (4.76 - 8.13) | 1997 | Modelled | IHME |
6.39 (4.83 - 8.19) | 1996 | Modelled | IHME |
6.47 (4.85 - 8.36) | 1995 | Modelled | IHME |
6.57 (4.87 - 8.52) | 1994 | Modelled | IHME |
6.64 (4.96 - 8.62) | 1993 | Modelled | IHME |
6.7 (5.01 - 8.70) | 1992 | Modelled | IHME |
6.77 (5.08 - 8.76) | 1991 | Modelled | IHME |
6.85 (5.15 - 8.91) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
3,196 (2,145 - 4,449) | 2019 | Modelled | IHME |
3,093 (2,083 - 4,273) | 2018 | Modelled | IHME |
3,016 (2,055 - 4,099) | 2017 | Modelled | IHME |
2,925 (1,991 - 4,011) | 2016 | Modelled | IHME |
2,889 (1,969 - 3,933) | 2015 | Modelled | IHME |
2,855 (1,987 - 3,838) | 2014 | Modelled | IHME |
2,807 (2,007 - 3,768) | 2013 | Modelled | IHME |
2,740 (1,995 - 3,645) | 2012 | Modelled | IHME |
2,695 (1,990 - 3,510) | 2011 | Modelled | IHME |
2,712 (2,017 - 3,526) | 2010 | Modelled | IHME |
2,726 (2,044 - 3,530) | 2009 | Modelled | IHME |
2,730 (2,059 - 3,518) | 2008 | Modelled | IHME |
2,716 (2,038 - 3,491) | 2007 | Modelled | IHME |
2,688 (2,014 - 3,461) | 2006 | Modelled | IHME |
2,658 (1,974 - 3,423) | 2005 | Modelled | IHME |
2,598 (1,937 - 3,323) | 2004 | Modelled | IHME |
2,530 (1,890 - 3,265) | 2003 | Modelled | IHME |
2,456 (1,868 - 3,157) | 2002 | Modelled | IHME |
2,422 (1,852 - 3,093) | 2001 | Modelled | IHME |
2,319 (1,775 - 2,968) | 2000 | Modelled | IHME |
2,196 (1,689 - 2,830) | 1999 | Modelled | IHME |
2,038 (1,562 - 2,620) | 1998 | Modelled | IHME |
2,006 (1,507 - 2,571) | 1997 | Modelled | IHME |
1,967 (1,485 - 2,521) | 1996 | Modelled | IHME |
1,936 (1,452 - 2,501) | 1995 | Modelled | IHME |
1,910 (1,418 - 2,479) | 1994 | Modelled | IHME |
1,878 (1,402 - 2,436) | 1993 | Modelled | IHME |
1,839 (1,376 - 2,390) | 1992 | Modelled | IHME |
1,806 (1,354 - 2,336) | 1991 | Modelled | IHME |
1,775 (1,333 - 2,309) | 1990 | Modelled | IHME |
1,749 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
20 (14 - 27) | 2019 | Modelled | IHME |
20 (14 - 27) | 2018 | Modelled | IHME |
20 (14 - 27) | 2017 | Modelled | IHME |
19 (13 - 26) | 2016 | Modelled | IHME |
19 (13 - 26) | 2015 | Modelled | IHME |
19 (13 - 26) | 2014 | Modelled | IHME |
19 (13 - 26) | 2013 | Modelled | IHME |
19 (13 - 25) | 2012 | Modelled | IHME |
19 (13 - 25) | 2011 | Modelled | IHME |
19 (13 - 25) | 2010 | Modelled | IHME |
19 (13 - 25) | 2009 | Modelled | IHME |
19 (13 - 25) | 2008 | Modelled | IHME |
19 (13 - 25) | 2007 | Modelled | IHME |
19 (13 - 25) | 2006 | Modelled | IHME |
19 (13 - 25) | 2005 | Modelled | IHME |
19 (13 - 25) | 2004 | Modelled | IHME |
19 (13 - 25) | 2003 | Modelled | IHME |
19 (13 - 25) | 2002 | Modelled | IHME |
18 (13 - 25) | 2001 | Modelled | IHME |
18 (13 - 25) | 2000 | Modelled | IHME |
18 (13 - 25) | 1999 | Modelled | IHME |
18 (13 - 25) | 1998 | Modelled | IHME |
18 (13 - 25) | 1997 | Modelled | IHME |
18 (13 - 25) | 1996 | Modelled | IHME |
18 (13 - 25) | 1995 | Modelled | IHME |
18 (13 - 25) | 1994 | Modelled | IHME |
18 (13 - 24) | 1993 | Modelled | IHME |
18 (13 - 24) | 1992 | Modelled | IHME |
18 (13 - 24) | 1991 | Modelled | IHME |
18 (13 - 24) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
2 (1 - 3) | 2016 | Survey/reported | Larney S et al, 2017 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
Overview
HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.38
(%)
2019, latest modelled
(0.31 - 0.45(%))
IHME
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines